Financial Shenanigans
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Forensic Read — Two Real Earnings-Quality Issues, No Smoke-Gun Concerns, Limited Filing History to Stress-Test
Powerica is a recently-IPO'd company (Apr-2026 listing). The investor toolkit available is essentially the March 2026 RHP (which contains 3 years of restated audited consolidated financials FY23–FY25 + H1FY26) plus the Q3FY26 disclosures. There is no concall transcript history, no analyst-day track record, and no opportunity to compare guidance with subsequent prints. With that caveat in mind, the substantive forensic findings are: (1) a clear one-time gain in FY24 PAT ($10.0M from divesting 16 wind turbines) that the headline P/E does not normalise, and (2) a Q3FY26 PAT optically inflated by a $7.9M deferred-tax credit (non-cash, one-off) from new-tax-regime adoption. Both items are correctly disclosed; the risk is that the reader does not adjust. Beyond those, accruals, related-party flows, and audit posture all read as normal-quality for an Indian mid-cap industrial.
CFO/EBITDA (FY21–25 avg)
FY24 One-off Gain ($ M)
Q3FY26 Tax Credit ($ M)
Related Party / Rev (FY25)
1. Earnings Quality
Two adjustments are required to read the trajectory cleanly.
(a) FY24 PAT contains an $10.0M exceptional gain from selling 16 wind turbines (26.4 MW capacity) located in Tamil Nadu. Per the RHP Restated P&L: profit-before-exceptional-items was $30M; exceptional gain $10.0M; PBT total $40M; PAT $26M. Net of exceptional gain (after applying the 34% effective tax rate) FY24 PAT was ~$19M. Properly disclosed; the investor risk is using the headline $26M in any normalised earnings or comparable-growth analysis.
(b) Q3FY26 reported PAT of $11M was inflated by a $7.9M deferred-tax credit from adopting the new corporate tax regime. Q3FY26 reported tax was negative $4.7M — a "tax credit" — versus an underlying tax expense that would have been ~$1.6M at the new regime's effective rate. Pre-credit Q3FY26 PAT was ~$3.5M. This is again properly disclosed (the company called it out explicitly in the investor presentation and press release), but the headline 9MFY26 EPS of $0.22 vs 9MFY25 $0.12 (+78%) is artificially flattered.
Both items pass the "properly disclosed" test but fail the "headline-comparable" test. Any peer multiple comparison using TTM PAT must adjust both items down, otherwise normalised P/E is materially overstated.
2. Cash-Flow Quality
CFO/EBITDA averaged 86% across FY21–25 (the FY21 print of 171% reflects working-capital release in a contracting year). FY23–25 sit comfortably in the 70–80% range — slightly below the 90%+ threshold typical of asset-light businesses but normal for a working-capital-intensive industrial with long-cycle MSLG projects. There is no evidence of factoring, securitisation, or supplier-finance arrangements being used to flatter operating cash flow. The disclosed schedule of "Other Financial Liabilities" in the H1FY26 balance sheet shows no jump in non-trade payable categories that would indicate hidden financing.
No CFO-shifting red flags. Working capital changes are visible and modest (FY25 used $5.0M of WC; FY24 used $3.2M; FY23 used $9.8M — all explained by inventory and receivables movements consistent with revenue mix shifts). No bank-mediated inventory sales, no factoring disclosure, no recourse-receivable arrangements that show up in the notes.
3. Key-Metric Discipline
The investor presentation includes share-of-associate-profit (Platino) inside reported EBITDA. This is acceptable Indian-GAAP / Ind-AS practice but worth tracking — a yellow flag because as Platino grows, its contribution to consolidated EBITDA becomes non-trivial ($1.1M FY25 vs $39M operating EBITDA, ~3%).
4. Balance-Sheet Pressure Points
Receivables grew faster than revenue in FY25 (+25% vs +20%), but the days-sales-outstanding only ticked up from 53 → 55. Acceptable. Inventory swings (FY25 down 23%, H1FY26 up 52%) reflect MSLG project rhythm — long-cycle projects sit in WIP for months. The CWIP buildup is the wind plant under construction. Borrowings doubled into H1FY26 to fund the capex peak — the IPO debt-paydown reverses this.
No "exploding other assets" flag. Other non-current assets jumped from $0.47M (FY25) to $15M (H1FY26) — the RHP attributes this to capital advances to wind-EPC contractors, traceable to the same CWIP buildup.
5. Related-Party & Promoter Exposure
The RHP discloses related-party transactions in the standard Ind-AS format. Aggregate RPT volume in FY25 is in the low single-digit percent of revenue. Watch the Oberoi-family vehicles for any growth in RPT scale post-listing — promoter ownership of 77.18% is on the higher end of recent IPOs and creates structural concentration of voting and economic power.
Note: Per the RHP, promoter Naresh Chander Oberoi is deceased; transmission of his equity shares is in process. The transmission has been disclosed and is administrative; not a flag, but the moving promoter cap-table requires monitoring.
6. Auditor & Governance Posture
7. The Forensic Scorecard
8. Bottom Line
Forensic verdict: clean by Indian mid-cap industrial standards, with two well-disclosed but non-recurring optical distortions in headline PAT (FY24 wind divestment gain; Q3FY26 deferred-tax credit). Both should be normalised out for any peer multiple work. No revenue-recognition concerns, no cash-flow manipulation, no capitalisation aggressiveness, no auditor red flags, no missing disclosures. The single biggest forensic limitation is the short-public-disclosure history — Powerica IPO'd Apr-2026 with no quarterly transcript track record to stress-test management commentary. Forensic conclusions for this name will firm up materially over the next 4–6 quarters.